Anti-ZMYND11 Antibody

Primary antibodies raised against ZMYND11 enable targeted detection of this transcriptional regulator in human-derived samples. Antibodies.com offers a rabbit polyclonal, unconjugated reagent validated for western blot and immunohistochemistry workflows. The 100 µl aliquot is supplied as a liquid and reacts with endogenous human ZMYND11, a chromatin-associated reader of H3K36me3 that participates in transcription elongation, RNA splicing control, and tumor-suppressor pathways studied in breast and hematologic cancers.

Researchers investigating epigenetic misregulation, alternative splicing mechanisms, or BS69-associated oncogenic signaling use this reagent to map protein expression across cell lines and tissue sections. Polyclonal coverage of multiple epitopes supports consistent recognition even where post-translational modification or isoform expression might mask monoclonal targets. The unconjugated format allows flexible pairing with HRP, fluorescent, or biotinylated secondaries depending on the detection chemistry a lab prefers.

Storage at 4 °C for short-term use and -20 °C for long-term preservation keeps activity stable across multiple freeze-thaw cycles when aliquoted. Each lot is supplied with reactivity confirmed against human antigen and is intended for research use only in academic and translational settings. Whether probing nuclear extracts by WB or localizing ZMYND11 in fixed tissue by IHC, the antibody provides a reliable foundation for chromatin and splicing biology studies.